About this trial
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Eligibility criteria
Qualifiers
Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
Open to trying a non-combusted oral tobacco product.
Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
Disqualifiers
Plan to quit smoking in the next 30 days.
Use of smokeless tobacco at least weekly in the last 6 months.
Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
Unwilling or unable to follow protocol requirements.
Trial design
Treatments tested in this trial
- Modified Risk - None
- Modified Risk Claim
Treatment groups
Sponsors and collaborators
Roswell Park Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator